Effect of Perioperative Dexmedetomidine Administration on Outcome in Cardiac Surgery Patients
NCT ID: NCT03091166
Last Updated: 2019-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
169 participants
INTERVENTIONAL
2016-12-31
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perioperative Dexmedetomidine and 30-Day Outcomes After Adult Cardiac Surgery
NCT07249164
Effect of Dexmedetomidine Preconditioning on Myocardial Ischemia-reperfusion Injury in Patients Undergoing Open Heart Surgery With Cardiopulmonary Bypass
NCT05598177
Dexmedetomidine and Long-term Outcomes in Elderly Patients After Cardiac Surgery
NCT03289325
Dexmedetomidine and Outcomes of Cardiac Surgery (DOCS)
NCT02237495
The Effect of Dexmedetomidine Infusion on Post-operative Cognitive Function and Oxidative Stress in Cardiac Surgery
NCT03054857
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dexmedetomidine
Dexmedetomidine
No Dexmedetomidine
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective surgery
* Use of CPB
Exclusion Criteria
* Reoperation
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Moscow Regional Research and Clinical Institute (MONIKI)
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oleg A. Grebenchikov
senior researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valery Likhvantsev, Professor
Role: PRINCIPAL_INVESTIGATOR
Moscow Regional Clinical and Research Institute, Moscow, Russia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PD-CS-2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.